Selenoprotein P is a plasma protein that has oxidant defense properties. It
binds to heparin at pH 7.0, but most of it becomes unbound as the pH is ra
ised to 8.5. This unusual heparin binding behavior was investigated by chem
ical modification of the basic amino acids of the protein. Diethylpyrocarbo
nate (DEPC) treatment of the protein abolished its binding to heparin. DEPC
and [C-14]DEPC modification, coupled with amino acid sequencing and matrix
-assisted laser desorption ionization-time of flight mass spectrometry of p
eptides, identified several peptides in which histidine and lysine residues
had been modified by DEPC. Two peptides from one region (residues 80-95) w
ere identified by both methods. Moreover, the two peptides that constituted
this sequence bound to heparin. Finally, when DEPC modification of the pro
tein was carried out in the presence of heparin, these two peptides did not
become modified by DEPC. Based on these results, the heparin-binding regio
n of the protein sequence was identified as KHAHLKKQVS-DHIAVY. Two other pe
ptides (residues 178-189 and 194-234) that contain histidine-rich sequences
met some but not all of the criteria of heparin-binding sites, and it is p
ossible that they and the histidine-rich sequence between them bind to hepa
rin under some conditions. The present results indicate that histidine is a
constituent of the heparin-binding site of selenoprotein P. The presence o
f histidine, the pK(a) of which is 7.0, explains the release of selenoprote
in P from heparin binding as pH rises above 7.0. It can be speculated that
this property would lead to increased binding of selenoprotein P in tissue
regions that have low pH.